The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
denileukin diftitox
A cytotoxic recombinant protein consisting of interleukin-2 (IL-2) protein sequences fused to diphtheria toxin. The IL-2 protein sequence moiety of denileukin difitox directs the cytocidal action of diphtheria toxin to cells that express IL-2 receptors. After the toxin moiety is internalized into target IL-2 receptor-expressing cells, its catalytic domain catalyzes the transfer of the ADP-ribose moiety of NAD to a posttranslationally modified histidine residue of elongation factor 2 (EF-2), called diphthamine. This covalent modification inactivates EF-2 and disrupts polypeptide chain elongation, resulting in cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | DAB(389)-interleukin-2 DAB389 interleukin-2 DAB389 interleukin-2 immunotoxin DABIL2 | |
| |||
| US brand name: | | ONTAK | |
| |||
| Abbreviations: | | DAB389IL2 DAB389-IL2 DAB389IL-2 | |
| |||
| Code name: | | LY335348 | |
| |||
